Pampigny, Switzerland

Marc Brugarolas

This inventor holds 1 USPTO granted patent. Top assignee: Ecole Polytechnique FÉDÉRALE De Lausanne (Epfl). Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Marc Brugarolas

Introduction

Marc Brugarolas is a notable inventor based in Pampigny, Switzerland. He has made significant contributions to the field of cellular biology through his innovative patent. His work focuses on understanding the mechanisms of cellular communication and the role of specific proteins in this process.

Latest Patents

Marc Brugarolas holds a patent titled "Method and system for determining intracellular mediators' activity." This patent describes a method for determining the presence of a molecule coupled to the cytoplasmic side of a cellular membrane. The method is implemented in a microfluidic setting and is particularly suitable for determining the presence and/or the activity of a G protein or an arrestin protein in a cell. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Marc Brugarolas is affiliated with the École Polytechnique Fédérale de Lausanne (EPFL), where he contributes to cutting-edge research in the field of cellular biology. His work at EPFL allows him to collaborate with other leading scientists and researchers, further enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include Thamani Dahoun and Margaux Duchamp. Their collaborative efforts contribute to the advancement of research in cellular mechanisms and the development of innovative methodologies.

Conclusion

Marc Brugarolas is a distinguished inventor whose work has the potential to advance our understanding of cellular processes. His innovative patent reflects his commitment to scientific research and innovation in the field of biology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…